Palisade Bio Inc (PALI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PALI Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Palisade Bio Inc's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent125.17
Cash & Short-term Investments125.00
Accounts receivable0.50
Derivatives, Collateral, Regulatory, Deferred0.07
Prepaid Expense And Other Assets Current2.28
Total Current Assets127.26
Equipment/Property/Plant Net0.00
Long-term investments0.06
Other Assets, Noncurrent0.00
Restricted Cash Noncurrent0.06
Operating Lease Right Of Use Asset-
Total Assets127.32
Liabilities
Accounts Payable, Current AC1.84
Accrued Liabilities, Current3.14
Other Liabilities, Current0.28
Total Current Liabilities5.25
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.06
Other liabilities, Noncurrent0.26
Share Liability Current-
Total Liabilities5.57
Stockholders' Equity
Retained Earnings Accumulated Income Deficit-162.33
Common Stock Value1.74
Additional Paid In Capital Common Stock292.91
Other Equity0.00
Common Stockholder's Equity121.75
Preferred Stockholder's Equity0.00
Total Stockholder's Equity121.75
Liabilities & Stockholder's Equity127.32
4 historic quarters locked

Sign in to unlock the full Palisade Bio Inc balance sheet history.

About Palisade Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001357459-26-000016

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.